JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women

Part of paid clinical trials in Harrison, New York.

Sponsor
Bonafide Health
Study ID
NCT07238478
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
50 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • JDS-HF3.0 — DIETARY_SUPPLEMENT
    Active Supplement JDS-HF3.0
  • Placebo — OTHER
    Nonactive Placebo

Study Details

The goal of this interventional study is to evaluate whether the study product can help improve quality of life and reduce common menopause symptoms-such as joint discomfort, hot flashes and night sweats-in women aged 50-70. The primary research question is whether taking the study product daily for 12 weeks can reduce the severity and frequency of menopause-related symptoms.

Key Dates

Start date
May 14, 2025
Status verified
Nov 2025
Primary completion
Jul 31, 2026
Completion
Oct 31, 2026

Study Design

Enrollment
250 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: JDS-HF3.0 Active Group
    Group of participants supplementing with JDS-HF3.0
  • Placebo Comparator: Placebo Comparator
    Group consuming nonactive placebo

Primary Outcome Measure

Change from Baseline in Menopause Related Quality of Life Outcomes [ Time Frame: From enrollment to the end of study at 12 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Bonafide HealthHarrisonNew York10528
Trisha VanDusseldorp, PhD
[email protected]
233-266-2343
Trisha VanDusseldorp, PhD (PRINCIPAL_INVESTIGATOR)
Austin Lamothe (SUB_INVESTIGATOR)
Michaela Alesi (SUB_INVESTIGATOR)
Laura Mason (SUB_INVESTIGATOR)
Stephen Carbonneau (SUB_INVESTIGATOR)

Find similar trials in Harrison, NY

By condition
Menopause
By specialty
Women's healthFertility
By research site
Bonafide Health· Harrison, NY

Related Studies